en

PRODUCT DETAIL

Clindamycin Noridem 150 mg/ml injekčný/infúzny roztok

Code 4013E
MA number 15/0168/23-S
Product Form: sol ijf 25x6 ml/900 mg (amp.skl.)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
MAH, country: Noridem Enterprises Ltd., Cyprus
Therapeutic Class: 15 - ANTIBIOTICA (PROTI MIKROB. A VÍRUSOVÝM INFEKCIAM)
ATC:
J ANTIINFECTIVES FOR SYSTEMIC USE
J01 ANTIBACTERIALS FOR SYSTEMIC USE
J01F MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
J01FF Lincosamides
J01FF01 Clindamycin
Shelf life: 24
Container: glass ampoule
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 14.07.2023
Validity: 14.07.2028
Pediatric indication: Yes
Pediatric posology: Yes
Pediatric warnings: Yes
PIL: PIL_Clindamycin Noridem 150 mg_ml injekčný_infúzny roztok_07 2023.pdf  
SPC: SPC_Clindamycin Noridem 150 mg_ml injekčný_infúzny roztok_05.2024.pdf  
Safety feature Unknown
Data update: 25.05.2024
eu-flag.png sk-flag.png